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Abstract
Background: Cervical cancer is a major health concern in Tanzania, caused by poor attendance for cervical cancer
screening and follow-up of women at risk. Mobile telephone health interventions are proven effective tools to improve
health behaviour in African countries. So far, no knowledge exists on how such interventions may perform in relation
to cervical cancer screening in low-income settings. This study aims to assess the degree to which a Short Message
Service (SMS) intervention can increase attendance at appointments among women who have tested positive for
high-risk (HR) Human Papillomavirus (HPV) during cervical cancer screening.
Methods/design: Connected2Care is a non-blinded, multicentre, parallel-group, randomised controlled trial. Tanzanian
women testing positive to HR HPV at inclusion are randomly assigned in an allocation ratio of 1:1 to the SMS intervention
or the control group (standard care). In a period of 10 months, the intervention group will receive 15 one-directional
health educative text messages and SMS reminders for their appointment. The total sample size will be 700 with 350
women in each study arm. Primary outcome is attendance rate for follow-up. Secondary objectives are cost-effectiveness,
measured through incremental ratios, and knowledge of cervical cancer by a 16-item true/false scale questionnaire at
baseline and follow-up. Barriers against implementing the intervention will be assessed in a mixed-methods sub-
population study.
Discussion: This study may provide information on the potential effects, costs, and barriers in implementing an SMS
intervention targeting a group of women who are followed up after testing positive for HR HPV and are, therefore, at
increased risk of developing cervical cancer. This can guide decision-makers on the effective use of mobile technology
in a low-income setting. Trial status: recruiting.
Trial registration: ClinicalTrials.gov, ID: NCT02509702. Registered on 15 June 2015.
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Background
Human Papillomavirus (HPV) is the most common
sexually transmitted infection in the world and approxi-
mately 80% of all sexually active persons will be infected
with HPV at some point during their lifetime [1, 2]. Per-
sistent high-risk (HR) HPV infection is a necessary first
step in developing cervical pre-cancerous lesions. A mi-
nority of these lesions progress to invasive cervical can-
cer over 10–20 years. The natural history of infection to
cancer is complex, and many factors influence this, in-
cluding the type of HPV, the number of sexual partners,
parity, other sexually transmitted agents, and host
susceptibility [3]. Cervical cancer often affects women of
reproductive age and is a major health challenge in low-
income countries (LICs) such as Tanzania where it ac-
counts for 38% (n = 7300) of all female cancers, and 34%
(n = 4200) of all female cancer-related deaths [1, 4].
Human immunodeficiency virus (HIV)-infected women
are at high risk of contracting HPV infection and devel-
oping cervical cancer. Further, cervical cancer screening
is limited in Tanzania and the screening uptake is poor
due to lack of knowledge of the disease and its preven-
tion. These factors are contributing to the large cervical
cancer burden in Tanzania, and the disease is a public
health concern with enormous social and economic
impact [1–3, 5–10]. It is yet to be estimated to which
degree women, who have attended screening and have
had abnormal test results, will attend follow-up screen-
ing appointments in African populations.
As with many other African nations, Tanzania is skyrock-
eting into the mobile era. By the end of 2014, 75% of the
population (34 million) had a mobile subscription [5]. The
opportunity to give mobile technology a formal role in
health care is increasingly being recognised [11]. The Min-
istry of Health in Tanzania has Mobile Health (mHealth) as
part of its electronic health strategy from 2013 to 2018 [12].
Randomised controlled trials (RCTs) have documented that
mobile technology can have a positive effect on both pa-
tients’ and health personnel’s behaviours in high- as well as
in low-income settings [11, 13–20]. In East Africa, mHealth
interventions have proven to increase attendance with
skilled delivery staff among pregnant women (by 13%);
adherence to anti-retroviral therapy among HIV-positive
patients (by 12–13%); attendance at post-operative clinic
visits among men who have been circumcised for HIV pre-
vention (by 5.7%); and correct malaria-case management
among health personnel (by 23–24%) [13–16, 20]. How-
ever, mHealth initiatives are still in their early days in LIC,
and for full effect it is key to consider literacy, cultural,
technical and scalability issues during implementation [11].
To our knowledge, no RCTs have previously tested the
degree to which text messages can improve cervical can-
cer screening behaviour and follow-up of women who
have had abnormal screening results. However, RCTs
from high-income countries have shown that educative
text messages and Short Message Service (SMS) re-
minders can significantly improve other types of cancer
preventive behaviour; for example self-reported skin
cancer prevention, breast self-examinations and breast
cancer screening attendance [17–19].
The present article describes the study protocol for an
RCT that aims to investigate the association between the
SMS intervention Connected2Care and attendance at
cervical cancer screening follow-up appointments
among HPV-positive women in Tanzania. Based on the
effect of other mHealth initiatives in LIC [14, 15, 21],
the hypothesis is that health educative text messages and
SMS reminders will increase by 15% the attendance rate
to follow-up appointments among HPV-positive women.
Additionally, in order to consider the real-world feasibil-
ity of implementing the intervention in a low-income
setting, the study aims to investigate the cost-
effectiveness of the intervention as well as barriers for
implementation.
Methods/design
Study objectives
Primary objective
 To assess the effect of an SMS intervention on
Tanzanian HPV-positive women’s attendance for
cervical cancer screening follow-up appointments at
14 months compared to standard care
Secondary objectives
 To estimate the cost-effectiveness of an SMS inter-
vention targeting Tanzanian HPV-positive women
who have a 14-month follow-up screening
appointment
 To assess the effect of an SMS intervention on
Tanzanian HPV-positive women’s knowledge of cer-
vical cancer and screening
 To understand barriers against the implementation
of an SMS intervention in Tanzania in a mixed-
methods sub-population study
Setting
The study will be conducted at three health facilities in
Tanzania—one in the Dar es Salaam Region and two in
the Kilimanjaro Region. All sites will be urban or semi-
urban areas. The study site in Dar es Salaam will be the
cervical cancer screening clinic at Ocean Road Cancer
Institute (ORCI). The two study sites in the Kilimanjaro
Region will be the reproductive health clinics and the
care and treatment clinics (CTCs) at (1) Kilimanjaro
Christian Medical Centre (KCMC) and (2) Mawenzi
Regional Referral Hospital in Moshi.
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Study design
Intervention
Connected2Care is a non-blinded, multicentre, parallel-
group, randomised controlled trial. Tanzanian women
testing positive to HR HPV at inclusion are randomly
assigned in an allocation ratio of 1:1 to the SMS inter-
vention or the control group (standard care). Once
women testing positive for HPV have been informed of
their test result, all eligible participants will be uploaded to
the SMS system used for the intervention. The randomisa-
tion will occur through an incorporated algorithm in the
SMS system and automatically assign 50% to a ‘no SMS
group’ (control group) and 50% to an ‘SMS group’
(intervention group). The control group will receive
standard care, which is a follow-up appointment at
14 months written on an appointment card. In
addition to standard care, the intervention group will
receive the SMS intervention (Fig. 1 Standard Proto-
col Items: Recommendations for Interventional Trials
(SPIRIT) Figure. For the full SPIRIT Checklist see
Additional file 1). The study is non-blinded due to the
nature of the intervention, which will be overt for both the
intervention group receiving the SMS and the control
group not receiving any SMS. Health personnel who screen
the women for cervical cancer will not be aware of the par-
ticipants’ randomisation status until they attend follow-up.
The SMS intervention will consist of 15 text messages
that will be sent to the intervention group over a period
of 10 months. There will be two types of text messages:
(1) educational text messages, and (2) SMS reminders for
the follow-up appointment. The cervical cancer educa-
tional messages will be sent once a month and concern
risk factors, common symptoms and screening informa-
tion. The SMS reminders will inform the women of their
appointment date and encourage women who have
missed their follow-up appointment to attend the
screening (Table 1). The reminders will be sent 2 weeks,
1 week and 1 day prior to the appointment date, as well as
1 day and 1 week after the appointment. The messages are
phrased in a polite, caring, educational and encouraging
manner. The messages were developed in English and
translated to Kiswahili in a standard forward with back-
ward translation. The maximum number of characters in
each message is 480 as this is equivalent to three text
messages. This is the maximum number of messages that
basic mobile phones can string together. This means that
each health educative text message or SMS reminder will
be received as one message on all mobile phones.
An external IT consultant has developed a web-based
SMS operating system for the study. The online operat-
ing system provides an overview of all text messages that
have been, or are scheduled to be, sent and shows the
following participant data: study number, mobile num-
ber, research site, enrolment and follow-up date, educa-
tion, and age. The operating system has a delivery note
feature that shows if there are any discrepancies between
the number of messages sent to a participant and the
number received. The text messages will be automatic-
ally dispatched through the operating system and will be
one-directional, meaning that the recipient cannot reply
Fig. 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure. Schedule of enrolment, intervention, and assessment
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to the SMS. The text messages will be sent with the ID
‘ElimuYaAfya’ (meaning ‘health education’ in Kiswahili). The
SMSs required for the intervention are attained from the
online Cloud SMS service ‘bulksms’ (www.bulksms.com).
The SMS service supports all mobile operators in Tanzania.
During the follow-up period, the SMS system will be
monitored on a monthly basis by the first author and the
external IT consultant in order to ensure that system is
functioning and text messages are being dispatched as
scheduled. The full trial profile is outlined in Fig. 2.
Pre-test of intervention
The messages were tested in a group of Tanzanian
women prior to implementation and specific attention
was given to the ethical aspects of receiving health infor-
mation on mobile phones as well as the content and the
timing of the messages. Two focus group discussions
were held with six to eight women attending screening
at ORCI and personal interviews were carried out with
four women at KCMC. The pre-tests showed that apart
from wanting to be informed about symptoms and the
importance of screening, ‘everyday life’ information was
important for the women (such as whether or not they
could continue to have sexual intercourse). These as-
pects were incorporated into the text messages. The pre-
tests further showed that the women preferred to receive
the messages in the afternoon (prior to cooking dinner)
or at night (after dinner time) as this was the ‘relaxation
period of the day’. Since mobile networks in Tanzania
can delay delivery of an SMS for up to 2 hours, it was
decided that the messages should be sent at 5 p.m.
Intervention framework and procedures
At inclusion, all eligible and consenting women will be
screened for cervical cancer using visual inspection with
acetic acid (VIA), tested for HIV using a quick HIV-1/2
test (www.alere.com), and tested for HR HPV using the
careHPV test® (www.qiagen.com). All women will be
given a follow-up appointment date after 14 months
where they will be re-screened using VIA and re-tested
for HIV (if HIV negative at inclusion). Women who test
VIA positive at inclusion will be treated on-site based on
National Cervical Cancer Service Delivery Guidelines,
which includes treatment with cryotherapy or loop elec-
trosurgical excision procedure (LEEP). During examin-
ation, if manifest cancer is diagnosed, women will be
managed based on the National Cervical Cancer Service
Delivery Guidelines whereby a biopsy will be taken, and
women will be referred for treatment at the oncology
clinic at ORCI. The policy of the Tanzanian government
is free cancer treatment for diagnosed patients whereby
the government covers all costs. At inclusion, all con-
senting women will be interviewed by a trained nurse
using a structured questionnaire. Questionnaire items
will include sociodemographic and covariate information
(including marital status, education level, HIV status,
smoking and alcohol habits, sexual history), knowledge
of screening and cervical cancer, as well as acceptance
of receiving health educative mobile text messages.
Contact information, including mobile phone number, will
be registered on a separate contact information form.
Study population and recruitment
The study is part of a larger research project, CONCEPT
(Comprehensive Cervical Cancer Prevention in Tanzania)
that started in August 2015 and finishes in December 2019
(Additional file 2).
CONCEPT is linked to the existing national cervical cancer
screening programmes in Dar es Salaam and Kilimanjaro.
The study population consists of HPV-positive
women who will be recruited as they visit the cervical
cancer screening clinics, the reproductive health clinics or
the CTCs at the study sites. To increase recruitment, fliers
Table 1 Health educative text messages and appointment
Short Message Service (SMS) reminders
Health educative text messages
Hello! We would like to wish you a good day.
The most common signs of cervical cancer are vaginal bleeding in
between your periods or contact bleeding, for example after sexual i
ntercourse. Another sign can be unusual discharge from the vagina.
If you experience any health problems, it is important to visit your
health clinic even before your next appointment. Thank you for
reading our message.
Hello! We would like to wish you a good day.
Often women cannot feel cervical cancer and it shows no signs at
an early stage. Therefore, it is important to go to screening even
though you do not feel sick or have symptoms of cervical cancer.
When cervical cancer is found at an early stage it can get treated.
Thank you for reading our message.
Hello! We are here to help you.
Women who have Human Papillomavirus can still have
sexual intercourse with their partner. Most often the body gets
rid of the infection on its own. The most common signs of cervical
cancer are vaginal bleeding in between your periods or contact
bleeding, for example after sexual intercourse. Another sign can be
unusual discharge from the vagina. When you go to screening, the
nurse can check and see if your cervix looks healthy. Thank you for
reading our message.
Appointment SMS reminders
Hello!
It is time for your screening appointment. Go to your health clinic
tomorrow. When you go to your screening appointment it will help
you to stay healthy and free of cervical cancer. We are here to help
you. Thank you for reading our message.
Hello!
You had a screening appointment 1 week ago. You are always
welcome at the health clinic at any time and get screened for
cervical cancer. When you go and get checked it will help you
to stay healthy and free of cancer. It is important that you stay
healthy for you and your family’s sake. Screening does not cost
you anything. Thank you for receiving our messages. This is the
last message. Thank you very much.
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informing about the screening will be shared at churches
and mosques close to the study sites.
Inclusion criteria
 Informed consent provided
 HPV-positive
 Age 25–60 years
 Owning a private mobile phone
Exclusion criteria
 Pregnant on the day of enrolment
 Menstruating on the day of enrolment
 Hysterectomy
 Diagnosed with cervical pre-cancer within past
12 months
 Diagnosed with cervical cancer
 Invalid mobile phone number
 Unreachable when trying to convey HPV-positive result
Fig. 2 Trial Profile
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Outcome measures
Primary outcome
The effect measure of the intervention is the 14-month
follow-up attendance rate for HPV-positive women.
Participants will be given a specific date for their follow-
up appointment at enrolment. However, as women can-
not attend screening during their menstrual period,
women often show up for their appointment within ±
2 weeks of their appointment. Further extenuating fac-
tors, such as work or family obligations or transportation
issues, are common in Tanzania. In order not to exclude
any women who may be delayed for such reasons,
attendance to follow-up will be measured as attending
up to 30 days past the appointment date.
Secondary outcomes
The cost-effectiveness of the intervention is estimated
through a conventional cost-effectiveness analysis based
on the RCT [22]. Two incremental cost-effectiveness
ratios (ICERs) will be calculated [23]; one with and one
without the costs of HPV testing. One ICER will reflect
all the costs related to this intervention (including HPV
testing), and the other will reflect the basic costs of
implementing an SMS intervention in a low-income set-
ting (excluding HPV testing).
A 16-item true/false questionnaire regarding cervical
cancer and screening will be used to measure the
effect of the intervention on HPV-positive women’s
level of knowledge. The questionnaire will be answered
by all participants at baseline and by the intervention
group at follow-up. The items reflect the health infor-
mation that will be sent to the intervention group
(Table 2).
Barriers for implementation of the intervention will be
described in a mixed-methods sub-population study that
combines quantitative and qualitative research methods
[24, 25]. The quantitative component uses questionnaire
items to measure acceptability, technical, and compre-
hension barriers. Acceptability will be measured through
a six-point Likert scale using smiley faces at baseline and
follow-up (Fig. 3). At follow-up, technical barriers and
knowledge barriers will be measured through binary
questionnaire items. The questionnaire outcomes will be
supplemented by a qualitative sub-population study
using individual interviews with women from the inter-
vention group. There is no set outcome measure for the
interviews as data are open-ended. The interviews will
be conducted using a thematic semi-structured interview
guide [26, 27].
Analysis plan
Sample size
During the inclusion period, 4000 women will be
screened for cervical cancer and it is expected that 950
(25%) women will test positive for HPV and that 25%
(250) of these women will be excluded from the
study due to there being no private mobile phone
access, invalid mobile phone numbers, or they will
be unreachable when trying to convey the HPV
result. It is hypothesised that the intervention will
increase attendance rates by 15%, and that 73% of
the intervention group and 58% of the control will
attend their follow-up appointment. A total dropout
rate of 15% is expected. In order to detect an
improvement in the intervention arm with a 95%
probability and a power of 80%, it is estimated that
350 women will be needed in each study arm, i.e. a
total sample size of 700. The sample size has been
calculated based on the formulas and the nomogram
in Altman’s paper [28].
Statistical methods
The primary analysis will be intention-to-treat and the
intervention arm (SMS) will be compared to the control
arm (standard care). Categorical variables will be expressed
in frequency and percentage. A logistic regression analysis
will be used to estimate the effect of the intervention; the
Table 2 The 16-item questionnaire to measure knowledge of
cervical cancer
Malaria (mosquito) causes cervical cancer True ❏ False ❏
Pain during urination can be a sign of cervical
cancer
True ❏ False ❏
Cervical cancer is the most common cancer
disease among Tanzanian women
True ❏ False ❏
You can get cervical cancer from deep kissing True ❏ False ❏
It is possible to prevent cervical cancer True ❏ False ❏
Vaginal bleeding is the most common sign of
cervical cancer
True ❏ False ❏
Too much sun can lead to cervical cancer True ❏ False ❏
A cervical infection will always turn into cancer True ❏ False ❏
HIV-positive women have higher risk of
developing cervical cancer
True ❏ False ❏
Cervical cancer is often found at an early stage
due to obvious symptoms
True ❏ False ❏
You can get cervical cancer from unprotected
sexual intercourse
True ❏ False ❏
Screening can detect cervical infections so they
do not develop into cancer
True ❏ False ❏
Cervical cancer is the main cause of cancer-
related death among women
True ❏ False ❏
Cervical cancer is most common for women in
their 20s
True ❏ False ❏
Itchiness in the vaginal area can be a sign of
cervical cancer
True ❏ False ❏
A virus called ‘Human papilloma virus’ (HPV)
causes cervical cancer
True ❏ False ❏
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14-month follow-up attendance rate as the dependent bin-
ary variable and the intervention/controls as the independ-
ent variable. Potential confounders and effect modifiers
(study site, region, educational level, age, HIV status, self-
perceived health, previous cervical cancer screening attend-
ance, marital status, cohabitors, religion) are addressed in a
subsequent multiple logistic regression analysis. Results are
expressed as odds ratios with 95% confidence intervals [29].
Demographic characteristics will be summarised using
descriptive statistics. Continuous variables will be expressed
as number of observed values, mean ± standard deviation,
median (range). Trial results will be reported by use of the
Consolidated Standards of reporting Trial (CONSORT)
criteria (www.equator-network.org).
Additional analysis
Cost-effectiveness evaluation
The cost-effectiveness analysis will include a 14-month
time perspective corresponding to the duration from in-
clusion until the follow-up contact. The effect measure
will be the same as in the RCT; 14-month follow-up at-
tendance rates for HPV-positive women. The costs of
the intervention will be estimated in US$ and include
the HPV test, resource-use related to the technical
development of the intervention, costs/SMS, and salaries
to health personnel. Data on resource-use will be col-
lected for each participating site based on available
budget and financial information. Further, the indirect
cost for not attending follow-up, i.e. the increased risk of
developing cervical cancer, will be addressed.
Knowledge of screening and cervical cancer
A comparative analysis will be made between the num-
ber and percentage of correct answers on the 16-item
true/false questionnaire at baseline and follow-up.
Mixed-methods sub-study
To obtain a more comprehensive account of barriers
and enhance the overall application of the intervention,
a qualitative component will supplement the question-
naire items used in the RCT [24]. After the intervention
period, approximately 15 semi-structured, individual
interviews will be conducted with participants from the
intervention group. The qualitative data will be analysed
according to a condensation of meaning analysis where
natural units of meaning are detected and coded into
central themes [24, 26, 27, 30]. The quantitative data
analysis of the statistical findings from the RCT will
entail a descriptive, comparative analysis. The quantita-
tive and qualitative data will not be fully integrated dur-
ing the interpretation of results. However, study results
will be compared and conclusions will reflect what has
been learned in a combination of the two studies [24].
Data management
To ensure anonymity, all study participants will be given
a unique study ID at inclusion and at follow-up. In-
formed consent and patient contact information will be
stored in secured, separate folders at ORCI and KCMC.
Copies of the contact information of HPV-positive
women will be shared with research assistants so they
are able to trace and visit the women. To monitor the
progress of enrolment, study ID, phone number, HPV,
HIV, and VIA status will be entered into an online elec-
tronic Excel® sheet on a weekly basis. To monitor the
progress of follow-up, baseline study ID, follow-up-study
ID, a date for a scheduled appointment and a date for
actual appointment attendance will be entered into an
online electronic Excel® sheet on a weekly basis. If the
actual attendance date is within 30 days of the scheduled
appointment date, the participant will be registered as a
‘turn-up’, otherwise as a ‘no-show’.
Data for the SMS intervention will be extracted from
the Excel® sheet and uploaded to the online operating
system manually once a month. The system has a private
domain and a one-direction encryption password is re-
quired to access the system. The system runs on a Cloud
service provided by Linode (www.linode.com). The do-
main name http://connected2care.org is registered from
Linode, and the system is accessed through this domain.
All data will be backed up on a weekly basis.
Fig. 3 Likert scale to measure acceptability of text messages
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Data will be entered and managed through the Research
Electronic Data Capture (REDCap) (www.project-redca-
p.org) and then exported to STATA v15 (www.stata.com).
REDCap ensures that data are stored at a secured, web-
based server at the University of Southern Denmark,
Odense. Only the first author and a data manager from
the University of Southern Denmark will have access to
the data. Electronic audio files will be stored on an online
secured server at the University of Southern Denmark.
Transcriptions will be anonymised.
Challenges in study implementation
All text messages will be sent using an online Cloud
SMS service. Originally, a stationary server with a pre-
paid SMS service located at ORCI was used for the
intervention. However, 6 months into the intervention
period random checks showed that the server was un-
stable and not dispatching the text messages as accord-
ing to the study plan. Therefore, the study team
transitioned to the online Cloud SMS service and re-
started the intervention 6 months into the study.
Already-enrolled patients kept their randomisation sta-
tus and may have received up to four text messages
twice. We will examine the effect on the transition on
this sub-group during the analysis.
Initially, only two study sites were part of the study,
ORCI and KCMC. However, due to delays in inclusion,
it was decided to add another site to the study in 2016,
Mawenzi Regional Referral Hospital. Further, the period
from the initial screening until women have been in-
formed of their positive HPV result has at times also
been prolonged, which has entailed that the first number
of text messages tend to bulk (are received at one time
instead of once a month). We will examine the effect of
this issue during a sub-group analysis.
Discussion
This study protocol describes an RCT that is designed
to improve attendance to cervical cancer screening
follow-up appointments in an African setting through
educational mobile text messages and appointment
SMS reminders. Additional to the RCT, the study
investigates the cost-effectiveness of the intervention
through a conventional cost-effectiveness analysis as
well as barriers for implementation through a mixed-
methods sub-population study. The study findings will
provide valuable information of the real-world feasibility
of implementing an SMS intervention in a low-income
setting, which can be a valuable tool for increasing
the effectiveness of screening services. There are several
elements of special importance in the study that are
worth outlining.
The study has had several implementation issues, i.e. chal-
lenges in relation to setting up a stable SMS service and
delays during inclusion. Despite LICs, such as Tanzania,
having moved into the mobile era, networks and Internet
tend to be unstable, which is challenging for a mobile inter-
vention such as Connected2Care. These issues must be en-
countered for in future planning of an SMS intervention
study or large-scale implementation in a similar setting.
The study tests women for HPV in addition to the regu-
lar VIA examination, which is standard care in Tanzania.
This test is introduced because research has shown that
the sensitivity of VIA is low compared to HPV testing [6].
It is important that the study participants understand
the meaning of the test and the health education that
they receive on their mobile phones. At inclusion, all
women are, therefore, given health education about
HPV and how it relates to cervical cancer as well as
information about the mobile intervention. A protocol
has been developed for how community health
workers deliver HPV-positive results to lay persons in
an ethically appropriate and consistent manner, and
how they will address any concerns the women may
have in relation to their result. Despite these precau-
tionary measures, there is a risk that study partici-
pants misinterpret an HPV-positive result as having
cervical cancer or do not understand the mHealth
education due to low health literacy [31, 32]. This
could have social and mental health consequences as
research shows that cervical cancer can be perceived
as a death sentence [32, 33]. Thirty days past the
follow-up appointment date, hospital nurses trace
women who have not attended their appointment.
The women are encouraged to come to the clinic for
screening and the importance of the follow-up appoint-
ment is explained. For ethical concerns, women who do
not have access to a private mobile phone are excluded
from this study, as text messages are considered too sensi-
tive for shared mobile phones. A possible consequence of
this is selection bias, since poorer women may not have
access to a private mobile phone and, therefore, may be
excluded.
Despite these issues, if, as expected, the mobile inter-
vention increases attendance to follow-up appointments
among women who have tested positive for HR HPV,
more women will be ensured an earlier follow-up, which
increases the chance of successful treatment and sur-
vival. Hereby, this study may help to improve the pre-
vention of cervical cancer in Tanzania.
Study duration/trial status
It is anticipated that the total duration of the study will be
3.5 years. The inclusion period started in August 2015 and
is anticipated to finish in the second half of 2017. The
follow-up period is 14 months. End of study will be in
2019. The study has been registered at ClinicalTrials.gov:
NCT02509702.
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